These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 12139862)
1. [Primary care research needs to be strengthened]. Vega Cubillo E; García Sánchez JA; García Ortega P; Carvajal A Aten Primaria; 2002; 30(3):191. PubMed ID: 12139862 [No Abstract] [Full Text] [Related]
2. Prevention of acute NSAID-related gastroduodenal damage: a meta-analysis of controlled clinical trials. Leandro G; Pilotto A; Franceschi M; Bertin T; Lichino E; Di Mario F Dig Dis Sci; 2001 Sep; 46(9):1924-36. PubMed ID: 11575445 [TBL] [Abstract][Full Text] [Related]
3. Gastroprotection during the administration of non-steroidal anti-inflammatory drugs. A drug-utilization study. Carvajal A; Arias LH; Vega E; Sánchez JA; Rodríguez IM; Ortega PG; del Pozo JG Eur J Clin Pharmacol; 2004 Aug; 60(6):439-44. PubMed ID: 15221157 [TBL] [Abstract][Full Text] [Related]
4. [Indications for anti-ulcer drugs in adults]. Chassany O Presse Med; 2000 Jan; 29(2):94-7. PubMed ID: 10682038 [No Abstract] [Full Text] [Related]
5. [Prevention of ulcer lesions under non-steroid antirheumatic agents. For each patient the appropriate stomach protection]. MMW Fortschr Med; 2004 May; 146(22):48. PubMed ID: 15373113 [No Abstract] [Full Text] [Related]
6. Primary prevention of ulcers in patients taking aspirin or NSAIDs. Med Lett Drugs Ther; 2010 Mar; 52(1333):17-9. PubMed ID: 20300052 [TBL] [Abstract][Full Text] [Related]
10. [Mucosa protective therapy with long-term nonsteroidal antirheumatic drugs]. Cozzarini W; Rath J; Bauer A; Györög I; Györög M; Prenner M; Trianto T; Maderbacher H; Höller E; Grusch B; Sebesta C Wien Med Wochenschr; 2003; 153(13-14):295-303. PubMed ID: 12924104 [TBL] [Abstract][Full Text] [Related]
11. Agents used in the prevention and treatment of nonsteroidal anti-inflammatory drug-associated symptoms and ulcers. Scheiman J; Isenberg J Am J Med; 1998 Nov; 105(5A):32S-38S. PubMed ID: 9855174 [TBL] [Abstract][Full Text] [Related]
12. Mitigating GI risks associated with the use of NSAIDs. Momeni M; Katz JD Pain Med; 2013 Dec; 14 Suppl 1():S18-22. PubMed ID: 24373106 [TBL] [Abstract][Full Text] [Related]
13. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment. Chan FK; Graham DY Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194 [TBL] [Abstract][Full Text] [Related]
14. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs. Prescrire Int; 2011 Sep; 20(119):216-9. PubMed ID: 21954519 [TBL] [Abstract][Full Text] [Related]
15. Prevention and management of NSAID-induced ulcers. Graham JA Am Pharm; 1992 Dec; NS32(12):62-4. PubMed ID: 1363026 [No Abstract] [Full Text] [Related]
16. Treatment strategies for the management of GERD in older adults. Slyk MP Director; 2005; 13(1):25, 27-32; quiz 33. PubMed ID: 17715870 [No Abstract] [Full Text] [Related]
17. Misoprostol and NSAID ulcers. Isaacs P Am J Gastroenterol; 1996 Feb; 91(2):187-8. PubMed ID: 8607480 [No Abstract] [Full Text] [Related]
18. Proton pump inhibitors for preventing non-steroidal anti-inflammatory drug induced gastrointestinal toxicity: a systematic review. Yang M; He M; Zhao M; Zou B; Liu J; Luo LM; Li QL; He JH; Lei PG Curr Med Res Opin; 2017 Jun; 33(6):973-980. PubMed ID: 28076696 [TBL] [Abstract][Full Text] [Related]
19. [Drug clinics. The drug of the month. Ranitidine bismuth citrate (Pylorid)]. Scheen AJ Rev Med Liege; 1998 Jan; 53(1):41-4. PubMed ID: 9555183 [TBL] [Abstract][Full Text] [Related]
20. [Prevention of NSAID-induced gastric lesions: H2 antagonists or misoprostol? A meta-analysis of controlled clinical studies]. Capurso L; Koch M Clin Ter; 1991 Dec 15-31; 139(5-6):179-89. PubMed ID: 1686995 [No Abstract] [Full Text] [Related] [Next] [New Search]